Home

Gland Pharma PE Ratio

Image

Gland Pharma Ltd

NSE: GLAND

PE

33.5

Last updated on: May 13, 2025

Key Highlights

  • The P/E Ratio of Gland Pharma Ltd is 33.5 as of 13 May 9.00 AM .
  • The P/E Ratio of Gland Pharma Ltd changed from 40.7 on March 2021 to 39.3 on March 2024 . This represents a CAGR of -0.87% over 4 years.
  • The Latest Trading Price of Gland Pharma Ltd is ₹ 1433 as of 13 May 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.1 to 40.1 in 5 years. This represents a CAGR of 13.70%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 26.2. The PE Ratio of Pharmaceuticals industry is 40.1. The PE Ratio of Retail industry is 139.8. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Gland Pharma Ltd

No data available

Company Fundamentals for Gland Pharma Ltd

Image

Gland Pharma Ltd

NSE: GLAND

Share Price

₹ 1433.9

3.30 (0.23%)

stock direction

Last updated on: May 13, 2025

Market Price of Gland Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Gland Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
13 May 20251433.9
12 May 20251430.6
09 May 20251426.3
08 May 20251413.5
07 May 20251403.45
06 May 20251414.2
05 May 20251418.75
02 May 20251404.7
30 Apr 20251398.35
29 Apr 20251413

SWOT Analysis Of Gland Pharma Ltd

Strength

2

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Gland Pharma Ltd

Asset Value vs Market Value of Gland Pharma Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Gland Pharma Ltd23624
Sun Pharmaceutical Industries Ltd407971
Divis Laboratories Ltd161153
Cipla Ltd122717
Torrent Pharmaceuticals Ltd109387
Mankind Pharma Ltd105125

PE Ratio of Gland Pharma Ltd Explained

23624

Market cap

704

Earnings

33.5X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Gland Pharma Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Gland Pharma Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Gland Pharma Ltd

No data available

* All values are in %

About Gland Pharma Ltd

  • Gland Pharma Limited was incorporated as Gland Pharma Private Limited', a private limited company on March 20, 1978 and was granted the certificate of incorporation by Registrar of Companies, Andhra Pradesh at Hyderabad.
  • Subsequently, the name of the Company was changed to Gland Pharma Limited' and a fresh certificate of incorporation dated April 25, 1995 was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.
  • The Company is primarily engaged in manufacturing injectable formulations. The company is one of the fastest growing generic injectables-focused companies by revenue in the United States from 2014 to 2019.
  • The company has 8 manufacturing facilities in India, comprising four finished formulations facilities with a total of 23 production lines and three API facilities.

Gland Pharma Ltd News Hub

Gland Pharma slides after Q1 PAT slumps 26% YoY to Rs 144 cr

Revenue from operations jumped 15.97% YoY to Rs 1,401.70 crore in Q1 FY25. Profit before tax (PBT) s

Read more

07 Aug 24

Gland Pharma consolidated net profit declines 25.94% in the June 2024 quarter

Net profit of Gland Pharma declined 25.94% to Rs 143.76 crore in the quarter ended June 2024 as agai

Read more

06 Aug 24

US FDA issues 3 Form 483 observations to Gland Pharma's Pashamylaram facility

The said inspection was conducted between 25 July 2024 and 02 August 2024. The said inspection was c

Read more

05 Aug 24

Gland Pharma Ltd gains for third straight session

Gland Pharma Ltd gained for a third straight session today. The stock is quoting at Rs 1936.35, up 1

Read more

09 Sept 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Gland Pharma Ltd

What is the current PE Ratio of Gland Pharma Ltd?

The Current PE Ratio of Gland Pharma Ltd is 33.54 as on 13 May 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.1 as on 13 May 2025.

What was the PE Ratio of Gland Pharma Ltd last year?

The PE Ratio of Gland Pharma Ltd was 26.75 last year, now the PE ratio is 33.54, showing a year-on-year growth of 25.4%.

What does the PE Ratio of Gland Pharma Ltd indicate about its stock?

The PE Ratio of Gland Pharma Ltd is 33.54. This ratio indicates that investors are willing to pay 33.54 times the earnings per share for each share of Gland Pharma Ltd.

What is the PE Ratio Growth of Gland Pharma Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Gland Pharma Ltd grew by 25.4% whereas, the EPS ratio grew by 25.1.

How does the PE ratio of Gland Pharma Ltd compare to industry peers?

The PE ratio of Gland Pharma Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Gland Pharma Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Gland Pharma Ltd PE Ratio.

What factors influence the PE ratio of Gland Pharma Ltd PE Ratio?

The PE ratio of Gland Pharma Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Gland Pharma Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Gland Pharma Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Gland Pharma Ltd PE Ratio?

You can check the latest PE ratio of Gland Pharma Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Gland Pharma Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Gland Pharma Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Gland Pharma Ltd PE Ratio predict future stock performance?

While the Gland Pharma Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions